| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5842322 | Life Sciences | 2013 | 6 Pages |
Abstract
These findings suggest that CD27âCD95+CD19+ and CD86+CD19+ B cells may be reasonable cellular targets for the therapeutic intervention of AS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xiao-Ying Niu, Hai-Yu Zhang, Yi-Jun Liu, Ding Zhao, Yu-Xing Shan, Yan-Fang Jiang,